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The development of techniques of photoscanning has made it 
possible to visualize lesions in many areas that  could not be studied 
by previous radiologic techniques. In  order to permit the visualization 
of an organ or lesion by this scanning technique, a substance must be 
labeled with a radioisotope having a gamma, x-ray or positron emission 
and must, of course, concentrate in the organ to be studied in such 
a way that  abnormalities of the organ can be seen as areas of increased 
or decreased uptake, relative to the rest of the organ. The concentration 
of the isotope must be low in surrounding organs that  come within the 
field of the scan. _As the distribution of a radioisotope depends upon the 
chemical form in which the isotope is given, further developments in 
t h e  field of scanning will very probably be critically dependent upon 
basic pharmacologic work. I t  is a medical axiom that  advances in 
therapeutics depend heavily upon basic pharmacologic investigations. 
But with the advent of photoscanning clinical medicine now has a diag- 
nostic technique in which further advances will also depend heavily 
upon basic pharmacologic work. Moreover, the concern of pharmacolo- 
gists in this area must lie more investigations of structure-distribution 
relations than structure-activity relations. 
The diagnostic localization of a radioisotope to permit scanning is 
similar to the therapeutic localization of a radioisotope to permit 
irradiation of a neoplasm or hyperplastic organ in that  both situations 
require high uptake in the targest tissue relative to the uptake in non- 
target tissue. But there is a significan¢ difference in that  the critical 
non-targest tissues in diagnostic localization are those anatomically 
adjacent to the target tissue whereas the critical non-target organs in 
therapeutic localization are those highly susceptible to radiation effect, 
such as bone marrow. 
• Dedicated to Professor OTTO KRAYER, with gratitude and respect, on the 
occasion of his sixty-fifth birthday. 
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The development  of labeled compounds  to permi t  scanning of 
various organs has been slowed by  the fact thas  m a n y  of the common 
const i tuents  of biologically impor t an t  compounds,  e.g., ni trogen, carbon, 
sulfur, etc. do no t  have radioisotopes with suitable emission and  half-life. 
However,  BLAU 2,3 subs t i tu ted  selenium for sulfur in  methionine  in  order 
to take advantage  of the gamma emission of selenium-75 in  scanning 
the pancreas. WILLIAMS 6-s had previously s tudied the d is t r ibut ion  of 
unlabeled thiouracil  and  thiourea in  exper imental  animals  and  man.  
He had found relat ively high concentra t ions  of these compounds in  
several organs of the body, including the adrenal  glands. We therefore 
under took  a s tudy  of the selenium analogs of thiouraci l  and  thiourea,  
labeled with Se 75, in  order to determine whether  such compounds  might  
permi t  the visual izat ion of the adrenal  glands or other organs by  scanning.  
M e t h o d s  
Selenouracil and selenourea, as supplied, had specific activities of 45 to 67/~c/mg 
and 1000/~c/mg, respectively*. To prevent oxidation, each compound was supplied 
in sealed vials, each vial containing 1 mc. All vials were kept at approximately 
- -  18 ° C. until use and exposure of the compounds to light and air was kept as 
brief as possible during the experiments. Selenouracil was dissolved in dimethyla- 
cetamide just before injection. Selenourea was received as an aqueous solution. 
Just before use it was mixed with a solution of sodium chloride to bring it to 
isotonicity and to adjust the radioactivity to the desired value. The activity of the 
labeled selenouracil and selenourea solutions, as injected, was 80 to 384/~c/ml 
and 95 to 1300/~c/ml, respectively. 
Thirty-five male rabbits, weighing approximately 3 kg each, were used. Of 
these, 21 received SeT~-selenouracil in doses of 40 to 250/~c intravenously. Four of 
the 21 died 1--12 minutes after injection. Eight were sacrificed, at times ranging 
from 1 hour to 30 days after injection of the isotope, by an excessive dose of pento- 
barbital sodium in isopropyl alcohol**. Directly after death, tissue samples (See 
Fig. 1) were taken and weighed and their radioactivity was determined in a well 
scintillation counter. Two rabbits were used only for scanning (see below) and 
tissues were not taken. Three received 6 to 8 doses of adrenocorticotropic hormone 
(ACTH)*** prior to receiving SeV5-selenouracil. Each dose was 3 clinical units, given 
intramuscularly at 12 hour intervals, the last dose being given on the morning 
the rabbit was to receive the radioisotope. Two rabbits received thiouracil, dissolved 
in their drinking water, for 2 days before the Se~-selenouracil was given. One of 
these was sacrificed 1 hour after the injection of the isotope; this rabbit had received 
approximately 250 mg of thiouracil. The other was sacrificed 5 days after injection 
of the isotope and continued to receive thiouracil in his drinking water until sacrifice ; 
he had received a total of 380 mg of thiouracil. As NaOH was required to dissolve 
the thiouracil, two other rabbits served as controls, drinking water of the same pH 
(8.0--8.2) without thiouracil. 
* These compounds were synthesized by the U.S. Nuclear Corporation, 
Burbank, California, under the direction of Dr. KARL AlgLAUER. 
** "Lethal" solution. Haver Lockhart Laboratories, Kansas City, Missouri, 
U.S.A. 
*** Acthargel, Armour Pharmaceutical Company, P.O.Box 511, Kankakee, 
Illinois, U.S.A. 
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Fig. 1. Tissue: blood concentration ratios for Se 7s in tissues of rabbits at various time after injection of 
Se75-1abeled selenouracil. 0nly the 11 tissues with highest concentrations of the radioisotope are 
shown in the figure. Other tissues and secretions studied included bone, bone marrow, fat, large 
intestine (i.e., the full thickness of the wall without the contents of the lumen), pancreas, skin, spleen, 
stomach, stomach contents, testes and pituitary. One rabbit was studied at each time indicated in the 
figure./, Lung; ,Li Liver; B Bile; Si Small Int; Sc Small Int cont; Lc Large Int cont; A Adrenal; 
T Thyroid; S Spleen; K Kidney; U Urine 
F o u r t e e n  r abb i t s  received Se~5-selenourea in doses  o f  40 to 200 #c  i n t r avenous ly .  
Eight of  t he se  were sacrificed a n d  t i s sue  s amp l e s  were t a k e n  20 m i n u t e s  to  3 d a y s  
a f te r  in jec t ion  o f  t h e  i so tope  (See Fig. 2). Four were u sed  on ly  for s cann ing .  Two 
rece ived  A C T H  before in jec t ion  o f  t h e  isotope.  One  of  t he se  received 7 a n d  t h e  
o the r  rece ived  8 doses ;  t h e  dose,  r ou t e  a n d  schedule  o f  in jec t ion  were t he  s a m e  as  
those  u s e d  pr ior  to  Se~5-selenouraeil in ject ion.  
Scans  were p e r f o r m e d  in  10 o f  t he  r abb i t s  t h a t  h a d  received selenouraci l ,  a t  
t imes  r ang ing  f rom 20 m i n u t e s  to  25 hou r s  a f te r  t h e  a d m i n i s t r a t i o n  o f  t he  isotope.  
A to t a l  o f  10 scans  was  pe r fo rmed  in 8 o f  t he  r abb i t s  t h a t  h a d  received se lenourea ,  
a t  t imes  r ang ing  f rom 25 m i n u t e s  to 7 d a y s  a f te r  a d m i n i s t r a t i o n  o f  t he  isotope.  
Scans  were u sua l l y  pe r fo rmed  be[ore sacrifice, w i th  t h e  r abb i t  u n d e r  p e n t o b a r b i t a l  
anes thes ia .  The  r abb i t s  were s c a n n e d  in  t he  p rone  or sup ine  posi t ion,  w i th  legs 
ex t ended .  T h e  field o f  t h e  s can  u s u a l l y  e n c o m p a s s e d  t he  t h o r a x  a n d  u p p e r  a b d o m e n .  
A commerc ia l ly  ava i lab le  p h o t o s c a n n e r * ,  emp l oy i ng  a 3 "  X 2 "  c rys t a l  a n d  19-hole 
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Fig.2. Tissue: blood concentration ratios for Se 7a in tissues of rabbits at various times after injection 
of Se'Llabeled selenourea. Only the 11 tissues with highest concentrations of the radioisotope are 
shown in the figure. Other tissues and secretions studied included bone, bone marrow, fat, large 
intestine, small intestine contents, skeletal muscle, pancreas, skin, spleen, stomach, stomach contents, 
testes and pituitary. Each of the 8 sets of data was obtained from a single rabbit; note that 3 rabbits 
were sacrificed 2 days after injection. L Lung; Li Liver; B Bile; Si Small Int ;  Lc Large Int  cont; 
A Adrenal; T Thyroid; Sg Salivary Gland; S Spleen; K Kidney; U Urine 
focusing collimator was used. Contrast amplification of scans was obtained by the 
use of closed circuit television, as described by BENDER and BLAU 1. 
Results 
Fig. 1 shows the organ:blood ratio of Se 75 concentration, i.e., [ S e  75] 
in the organ/[Se 75] in blood, after administrat 'on of SeTZ-selenouracil in 
the 8 rabbits sacrificed for tissue counts plus one rabbit  tha t  died 
11 minutes after injection. Only tissues with relatively high concentra- 
tions of Se 75 are shown in the figure; tissues with lower concentrations 
are noted in the legend. Renal concentration and urinary excretion of 
the isotope obviously play a prominent role after administration of 
Se75-selenouracil. Hepatic concentration and biliary excretion also appear  
significant. The highest relative concentration in the adrenal glands 
appears at  5 days in this small series of animals, but  even at  this t ime 
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Fig .3 .  Se in t igram of  a rabbi t  a f te r  admin i s t ra t ion  of  Se~a-selenouracil. Dorsal  view.  One hundred  ~c 
was g iven  in t ravenous ly  51/2 hours  before scanning,  which was carr ied out  under  pentobarbi ta l  
anesthesia .  The outl ines of  the  body wall and  lower costal marg ins  have  been projected onto the  scan. 
Af te r  complet ion of  the scan the  rabbi t  was sacrificed while still in scanning position. The lungs, 
d i a p h r a g m  and  l iver were t ransfixed and  held in posit ion wi th  long needles inserted through the  skin. 
The thorax  and  abdomen  were opened for inspection. The upper  horizontal  lines d rawn a t  each side 
of  the  body  wall  show the highest  level reached by  the  l iver under  the curve  of  the d i a p h r a g m  in 
expirat ion.  The lower lines show the lowest level reached by  the  lungs curv ing  over  the  d iaphragm.  
The  upper  " X "  shows the lowest cervical  ver tebra .  The lower " X " ,  a t  the apex  of  the inferior costal 
marg ins ,  shows the lowest thoracic ver tebra  
the concentration in the liver is greater than in the adrenal gland. 
A remarkable finding is the high concentration of Se ~5 in the lung, noted 
throughout all the early hours after injection. 
Fig.2 shows the [SeV5j in organs/[Se v5] in blood in 8 rabbits after 
administration of Se75-selenourea. Renal and hepatic excretion of the 
isotope are important  after injection of SeVS-selenourea. The highest 
[Se :5] in adrenal glands/[Se v5] in blood after injection of Sc~5-selenourea 
is found at  2 days, among the times measured. A high pulmonary con- 
centration of Se v5 is found after administration of labeled selenourea; 
although a larger number  of animals would obviously be required to 
establish the precise t ime of peak concentration, this appears to come 
at  a later t ime after injection of selenourea than  after injection of selen- 
ouracil. 
Prior - adminis t ra t ion of ACTH did not significantly influence 
adrenal uptake of Se v5 in these experiments. The rabbits tha t  re- 
ceived stable thiouracil did not show significant differences from their 
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controls in the tissue distribution of Se 75 after administration of Se 75- 
selenonracil. 
Fig.3 shows the scan of a rabbit  obtained 51/2 hours after injection 
of 100/~c of selenouracil. The outline of the lungs is visible, most evident 
in the lower lobes, where the density due to the concentration of Se 75 
in the lungs is superimposed on that  due to concentration of radioisotope 
in underlying liver. 
Of the two compounds, the use of labeled selenouracil allowed better  
scans. The lungs were best demonstrated in scans taken early after 
administration of selenouracfl, while later times proved better  in the 
case of selenourea. 
Discussion 
The concentration of radioisotope in each organ is reported as con- 
centration relative to tha t  in blood rather than  absolute concentration, 
for the organ : blood ratio is more helpful than the absolute concentration 
in predicting the usefulness of a labeled compound for scanning. The 
distribution of Se 75 after administration of the two compounds studied 
here suggested the following: these compounds should permit demon- 
stration of the lung by scanning; no serious interference from other 
intrathoracic organs should be expected; the principal interference 
would be expected to come from the liver; the lungs would probably 
be best demonstrated in scans taken early after administration of 
selenouracil, while later times would be better  in the case of selenourea; 
the former compound would permit better  visualization of the lungs. 
These predictions were confirmed by  actual scans. 
The concentration of radioisotope in the lung after administration 
of these compounds is of interest. Our experiments do not permit us 
to say in what form the radioisotope is present in the lungs, or whether 
it is present in significant concentrations in expired air, but it should be 
noted tha t  individuals poisoned with selenium excrete the metal  in 
expired air, presumably in the form of methyl  selenide. Hepatic con- 
centration and biliary excretion, renal concentration and urinary excre- 
tion of radioisotope after administration of these compounds are not 
surprising. In  one rabbit  receiving selenourea, a high concentration in 
the wall of the large intestine was observed twenty-four hours after 
injection. Although colonic excretion of metals is well-known, this single 
observation, not found in rabbits studied at other times in our experi- 
ments, must  be accepted with caution. Similarly, the demonstration 
of an unusually high concentration of radioisotope in the heart of one 
rabbit  30 days after administration of selenouracil is of interest, but it 
must  also be accepted with the caution that  a single observation deserves. 
In  view of the potential importance of pulmonary scans in demon- 
strating certain lesions (e.g., pulmonary infarcts) not easily detected by 
Distribution of Se75-selenouracil and Se75-selenourea 293 
present roentgenologic techniques, the question of practical clinical use of 
Se75-selenouracil arises. These compounds do not seem to give sufficiently 
good scans to make them of practical importance. The scan shown in 
Fig. 3 is greatly inferior in quality to the scans of such organs as liver, 
kidney, heart  (myocardium), etc. tha t  we can now routinely obtain in 
experimental animals and in man by the use of other labeled compounds. 
A second disadvantage is the toxicity of the compounds used in this 
study. Among the 4 rabbits dying after injection of selenouracil, two 
received an estimated dose of 1.5 rag, one received 3.5 mg and one 
received 8.8 mg of the compound. All of the rabbits  tha t  died after 
injection showed considerable dyspnea before death. No rabbits died 
after selenourea injection. There may  be a real difference in the toxicity 
of the two compounds, but the higher specific activity or greater solubility 
of the selenourea may  very well have accounted for its greater safety. 
In  any event, the problems of solubility and toxicity with either com- 
pound could be greatly ameliorated by the production of compounds 
of still higher specific activity. A third problem, hepatic interference, 
is a much more difficult one. This is a well-known phenomenon with 
scans of several other organs. This interference is due to an unfortunate 
combination of circumstances,-- the large mass of the liver, its "strategic" 
position in relation to thoracic and abdominal fields and its capacity to 
concentrate an extraordinary var iety of substances. Although tissue 
absorption cannot be entirely ignored, organs of large size will in general, 
of course, emit more radiation than smaller organs when the concentra- 
tion of isotope per gram of each organ is the same. This puts the lung 
at  a serious disadvantage, as much of the lung volume in vivo is air 
rather  then tissue. Taking all three disadvantages into consideration, 
it should be definitely stated tha t  neither of the two compounds studied 
here is recommended for a trial of scanning in human patients. Other 
techniques of pulmonary scanning, which are being developed by  other 
workers, seem to offer more promise. 
Finally, the relation of our experiments to the possibility of demon- 
strating the adrenal gland by scanning deserves mention. With the 
limitations of resolution of our present scanning apparatus,  it is unlikely 
tha t  the adrenal glands of rabbits  could be demonstrated with great 
accuracy by scanning but the human adrenal glands are large enough 
to permit such a demonstration, provided the proper labeled compound 
to concentrate in the adrenals is found. In  view of the limitations of 
other methods of s tudy of the physiology and pathology of the adrenal 
gland, the development of adrenal scanning would probably represent 
a greater advance than the development of pulmonary scanning. Al- 
though appreciable adrenal:blood ratios were found in our experiments 
with selenourea and selenouracil, the ratios were not sufficiently high, 
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especially in comparison with the ratios in surrounding organs, to make 
these compounds useful in adrenal scanning. I t  is possible that  a return 
to the sulfur-containing compounds themselves, instead of their selenium 
analogs, might be more fruitful. For the sulfur compounds, another 
method of labeling will be needed. 5-iodo-2-thiouracil (iodothiouracil) 
has been synthesized and actually used in clinical medicine. I f  this 
compound were labeled with radioactive iodine, it might permit adrenal 
scanning. We have initiated preliminary work to investigate this possi- 
bility. 
More significant is the demonstration of CH]~OWETH 4 that  certain 
anesthetics are preferentially concentrated in the adrenal gland. Al- 
though Chenoweth's experiments did not employ labeled compounds, 
the adrenal concentration of halothane, CFaCHBrC1, and methoxy- 
flurane, CHaOCF2CHCI~, are noteworthy. We believe that  several 
members of the series of halogenated hydrocarbons, if properly labeled, 
may offer significant aid in the development of adrenal scanning. 
Although ordinarily given as inhalation anesthetics, some of the com- 
pounds in this series have already been used by other workers 5 in 
injectible emulsions for anesthesia. Using compounds of high specific 
activity, it should he possible to inject emulsions sufficient for a trial 
of adrenal scanning without anesthetic effect. 
We consider that  compounds of the following structure deserve 
a trial in adrenal scanning: 
RCF~I and RCF2CXYI, 
where R ~ CH30, CH~CH20, H or any halogen and X and ¥ ~ t t  or 
any halogen. 
Simpler halogenated hydrocarbons, not containing fluorine, and com- 
pounds of longer chain length than those shown here are also of interest, 
as are symmetrical substituted ethers. We are now carrying out prelimi- 
nary investigations with both fluorinated and non-fluorinated hydro- 
carbons of the type described above, the radioactive label being the 
iodine atom(s) in the molecule. The presumable fat solubility of such 
compounds also suggests possible usefulness in brain scanning, though 
our preliminary results with these compounds have been..more encourag- 
ing with respect to concentration in the adrenal glands than in the brain. 
Summary 
With the development of photoscanning clinical medicine now 
possesses a diagnostic technique in which further advances will depend 
heavily upon pharmacologic investigations of structure-distribution 
relations: In  the present study the distribution of the selenium analogs 
of thiouracil and thiourea, labeled with Selenium-75, was studied in 
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rabbits. After administration of either compound, high concentrations 
of Se v5 were found in the lung, liver and kidney. The concentration of 
Se 75 in the lungs after administration of these compounds, especially 
Se75-selenouraeil, permitted visualization of the lungs in the living, 
intact animal by photoseanning. However, neither Se75-selenouraeil nor 
Se75-selenourea permit pulmonary scans of high quality and these 
particular compounds are not recommended for trial in man. The 
possible relation of labelled compounds of this type, as well as certain 
other series of labeled compounds, to the problem of adrenal scanning 
is also discussed. 
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